CN Patent

CN104341362B — 三氮唑磺酰丙二酸类化合物、其制备方法及用途

Assigned to Shandong Industry Research Institute Zhongke High End Chemical Industry Technology Research Institute Co ltd · Expires 2016-07-13 · 10y expired

What this patent protects

本发明涉及与高尿酸血症和痛风相关的药物领域。具体而言，本发明涉及一类含三氮唑磺酰丙二酸结构的尿酸转运体1抑制剂、其制备方法、及含有它们的药物组合物以及它们在制备糖尿病药物中的应用。 其中，R选自H，C 1 ?C 8 的烷基、C 3 ?C 6 环烷基。

USPTO Abstract

本发明涉及与高尿酸血症和痛风相关的药物领域。具体而言，本发明涉及一类含三氮唑磺酰丙二酸结构的尿酸转运体1抑制剂、其制备方法、及含有它们的药物组合物以及它们在制备糖尿病药物中的应用。 其中，R选自H，C 1 ?C 8 的烷基、C 3 ?C 6 环烷基。

Drugs covered by this patent

Patent Metadata

Patent number
CN104341362B
Jurisdiction
CN
Classification
—
Expires
2016-07-13
Drug substance claim
No
Drug product claim
No
Assignee
Shandong Industry Research Institute Zhongke High End Chemical Industry Technology Research Institute Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.